Status | Study |
Recruiting |
Study Name: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization Condition: Choroidal Neovascularization Date: 2016-08-21 Interventions: Drug: 0.5mg intravitreal ranibizumab Patients received ranibizumab (0.5mg, Novartis AG, Basel, Switzerla |
Recruiting |
Study Name: Intravitreal Conbercept for Idiopathic Choroidal Neovascularization Condition: Idiopathic Choroidal Neovascularization Date: 2016-07-27 Interventions: Drug: conbercept 0.05ml conbercept Other Name: conbe |
Recruiting |
Study Name: 68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis Condition: Pathological Angiogenesis Date: 2016-01-24 Interventions: Radiation: 68Ga-NODAGA-RGD PET/CT |
Not yet recruiting |
Study Name: Strategies for Management of Corneal Neovascularisation Condition: Corneal Neovascularisation Date: 2015-10-27 Interventions: Device: Fine Needle Diathermy |
Withdrawn |
Study Name: Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID). Condition: Choroidal Neovascularization in Angioid Streaks Date: 2015-10-07 Interventions: Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o |
Active, not recruiting |
Study Name: Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases Condition: Neovascularization, Pathologic Date: 2015-05-15 Interventions: Drug: ACM-1 intravitreal injection with 50ul ACM-1 at a concentration of 1600ug/ml |
Recruiting |
Study Name: Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3) Condition: Type 3 Choroidal Neovascularization Date: 2014-12-10 Interventions: Drug: Aflibercept |
Recruiting |
Study Name: Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization Condition: Choroidal Neovascularization Date: 2014-10-06 Interventions: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) Administration by intravitreal injection |
Completed |
Study Name: Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization Condition: Choroidal Retinal Neovascularization Date: 2013-12-31 Interventions: Drug: Aflibercept Injection Aflibercept intravitreal injection |
Completed |
Study Name: Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. Condition: Choroidal Neovascularization (CNV) Date: 2013-04-23 Interventions: Drug: Ranibizumab Ranibizumab |